AG0039A1

114-07-8 | [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione

Chemical structure of [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione, CAS 114-07-8
AG0039A1
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 114-07-8
Catalog Number AG0039A1(AGN-PC-0P5RUK)
Chemical Name [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
IUPAC Name (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
InChI InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
InChI Key ULGZDMOVFRHVEP-RWJQBGPGSA-N
MDL Number MFCD00149235
Molecular Formula C37H67NO13
Molecular Weight 733.9268
NSC Number 756759
SMILES C[C@@H](C([C@H](C)C[C@](O)(C)[C@H](O[C@@]2([H])[C@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[C@@H](C)[C@H](C[C@@]3([H])C[C@](OC)(C)[C@@H](O)[C@H](O)O3)[C@H]1C)=O)[C@@H](O)[C@@](O)(C)[C@@H](CC)OC1=O
UNII 63937KV33D
Synonyms
Erycette, Erymax, Erythromycin, Erythromycin A, Erythromycin C, Erythromycin Lactate, Erythromycin Phosphate, Ilotycin, Lactate, Erythromycin, Phosphate, Erythromycin, T Stat, T-Stat, TStat, erythromycin, Erythromycin A, 114-07-8, E-Mycin, Abomacetin, Erythrocin, Erythromycinum, Erymax, Ilotycin, Erythromycine, Eritromicina, Emgel, Robimycin, Erythro-Statin, E-Glades, E-Base, erythro, Benzamycin, Dumotrycin, Mephamycin, Eryacne, Sansac, Eryc Sprinkles, Erythra-Derm, Akne-Mycin, Erythromycin base, R-P Mycin, (-)-ERYTHROMYCIN, Wemid, E-Solve 2, Torlamicina, Abboticin, Erycette, Eryc 125, Ery-Tab, Erythroguent, Eritrocina, Erycinum, Erythrogran, Erythromid, Pantomicina, Propiocine, Stiemycin, Dotycin, Ermycin, Erycen, Erycin, Eryderm, Erygel, Ilocaps, Aknin, ERYC, Pfizer-E, Theramycin Z, Kesso-Mycin, Taimoxin-F, Ak-Mycin, Erythromast 36, Erythromycin Lactate, T-Stat, Endoeritrin, Eritomicina, Erythroderm, Erytrociclin, MFCD00084654, Paediathrocin, Pharyngocin, Proterytrin, Acneryne, Acnesol, Aknemycin, Derimer, Deripil, Erisone, Eryacnen, Erydermer, Eryhexal, Erysafe, Iloticina, Latotryd, Lederpax, Mercina, Oftamolets, Pantoderm, Pantodrin, Primacine, Romycin, Stiemicyn, Tiloryth, Tiprocin, Emuvin, Emycin, Erecin, Erymed, Erytab, Erytop, Inderm, Retcin, AustriaS, Eros, Ery-maxin, Erythro-Teva, Sans-acne, Erimycin-T, Ery-Diolan, Inderm Gel, Del-Mycin, UNII-63937KV33D, Wyamycin S, Aknederm Ery Gel, Udima Ery Gel, Emu-Ve, Erythrocin stearate, Skid Gel E, Akne Cordes Losung, Ilosone (estolate), E-Mycin (base), Ery-Tab (base), E-Base (base), Emu-V, Ery-B, CHEMBL532, ERYC (base), C-Solve-2, ERYTHROMYCIN STEARATE, PCE Dispertab (base), IndermRetcin, erythromycin-A, Eryc-125, Eryc-250, CHEBI:42355, ULGZDMOVFRHVEP-RWJQBGPGSA-N, Eritromicina [INN-Spanish], Erythromycine [INN-French], Erythromycinum [INN-Latin], A/T/S, Oftalmolosa Cusi Eritromicina, 63937KV33D, Ilotycin gluceptate, NCI-C55674, DSSTox_CID_2991, (-)-Erythromycin, 98%, UNII-8HPH7ND0LN, DSSTox_RID_76820, DSSTox_GSID_22991, 8HPH7ND0LN, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione, ERY, Ilotycin T.S., (-)-Erythromycin, Eur.Ph., CCRIS 9078, HSDB 3074, N-Methylerythromycin A, EINECS 204-040-1, NSC 55929, Ery-Sol, Staticin (TN), (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan-13-olide, Akne-mycin (TN), AI3-50138, Erygel (TN), Eryc (TN), T-stat (TN), Pce (TN), SR-05000001618, Sentry AQ mardel maracyn, erthromycin, Erythromycines, ULGZDMOVFRHVEP-UHFFFAOYSA-N, NSC55929, NCGC00094670-01, Erythromycin [USP:INN:BAN:JAN], 82343-12-2, CAS-114-07-8, Prestwick_205, Erythromycin C-13, E-mycin, Erythrocin, Erythromycin(E-Mycin), Spectrum_000115, Spectrum_000659, AC1L1ZUR, EM-A, Prestwick3_000151, Spectrum2_000759, Spectrum2_001263, Spectrum4_000538, Spectrum5_001596, E0751, Erythromycin A, B + C, EC 204-040-1, SCHEMBL2601, BSPBio_000282, BSPBio_002480, KBioGR_001175, KBioSS_000555, KBioSS_001139, MLS001066618, BIDD:GT0017, DivK1c_000294, DivK1c_000397, DivK1c_000702, SPECTRUM1500280, SPBio_000778, SPBio_001226, BPBio1_000312, GTPL1456, CHEMBL3735423, DTXSID4022991, Erythromycin (JP17/USP/INN), HMS500O16, KBio1_000294, KBio1_000397, KBio1_000702, KBio2_000555, KBio2_001139, KBio2_003123, KBio2_003707, KBio2_005691, KBio2_006275, Erythromycin (mixture of A,B,C), NINDS_000294, NINDS_000397, NINDS_000702, ZX-AFC000696, HMS1920M04, HMS2091D05, HMS2095O04, HMS3712O04, Pharmakon1600-01500280, ACT03320, HY-B0220, RKL10096, Tox21_111311, Tox21_111869, Tox21_300515, BDBM50344942, CCG-38992, LMPK04000006, NSC756759, ZINC85534336, Erythromycin, labeled with carbon-13, AKOS015895249, CS-2168, DB00199, MCULE-4566208867, NSC-756759, IDI1_000294, IDI1_000397, IDI1_000702, SMP1_000119, NCGC00179619-01, NCGC00179619-02, NCGC00179619-03, NCGC00254234-01, AC-12744, AC-12901, BC205124, CC-27517, CPD000544946, SAM002643510, SC-13736, SMR000544946, Erythromycin, potency: >=850 mug per mg, Erythromycin, tested according to Ph.Eur., SBI-0051368.P003, Erythromycin, N-demethyl-N-(methyl-11C)-, LS-187077, Erythromycin, meets USP testing specifications, C01912, D00140, E-3250, Erythromycin, plant cell culture tested, ~98%, 44496-EP2272846A1, 44496-EP2275422A1, 44496-EP2292608A1, 44496-EP2305644A1, 44496-EP2308866A1, 44496-EP2311814A1, 44496-EP2311828A1, 44496-EP2380568A1, AB00051981_09, AB00051981_10, Erythromycin standard solution, 1 mg/mL in H2O, Erythromycin, Biotechnology Performance Certified, 114E078, C-23475, SR-01000799155, 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, Erythromycin, Antibiotic for Culture Media Use Only, Erythromycin, BioReagent, suitable for cell culture, SR-01000799155-2, SR-05000001618-1, SR-05000001618-2, BRD-K63550407-001-13-5, BRD-K63550407-028-03-9, Erythromycin A, British Pharmacopoeia (BP) Reference Standard, Erythromycin A, European Pharmacopoeia (EP) Reference Standard, Erythromycin, United States Pharmacopeia (USP) Reference Standard, Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard, Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name), 215031-94-0, Bristamycin, Erypar, Erythromycin C, Staticin, Benzamycin Pak, Erythromycin B, Abboticine, Gallimycin, Qidmycin, Eratrex, Ilosone, Meberyt, Ethril, TStat, Dowmycin E, Erythromycin oxime, Ilotycin T.S, T Stat, Ethril 250, Serp-AFD, Ilosone (TN), Erythromycin thiocyanate, Erythromycin Ointment, erythromycin lactobionate, Erythromycin phosphate, Lactate, Erythromycin, Erythromycin intravenous, Phosphate, Erythromycin, 3''-O-Demethylerythromycin, erythromycin ethylsuccinate, Erythromycin glucoheptonate, D02YIZ, Erythromycin [INN:BAN:JAN], Erythromycin & VRC3375, ERYTHROMYCIN ESTOLATE, E-mycin, Erycin, Robimysin, ETHRIL 500, UNII-LXW024X05M, Erythromycin stearate (salt), ERYTHROMYCIN GLUCEPTATE, Erythromycin, stearate (salt), Erythromycin [BAN:INN:JAN], Erythromycin steraric acid salt, CCRIS 1504, OE 7, Erythromycin (JP15/USP/INN), HSDB 4178, Erythromycin octadecanoate (salt), Erythromycin stearate [BAN:JAN], Erythromycin octadecanoate (1:1), Erythromycin sodium lauryl sulfate, C37H67NO13, Erythromycin, octadecanoate (salt), ERYTHROMYCIN USP GRADE 10G, CID12560, DRG-0279, EINECS 211-396-1, C37-H67-N-O13, Erythromycin stearate [USP:BAN:JAN], ACN-048190, CS-O-01436, CS-O-11641, Octadecanoato de Eritromicina, (1:1), C37H67NO13.C18H36O2, NCGC00160521-01, adecane-2,10-dione (non-preferred name), B1939, Stearic acid, compd. with erythromycin (1:1), C37-H67-N-O13.C18-H36-O2, D004917, Octadecanoic acid, compd. with erythromycin (1:1), PCE, Erythromycin, 88%, potency:>/=920 u/mg - 25G 25g, Erythromycin, compd. with monododecyl sulfate, sodium salt, 643-22-1, 7704-67-8, EM, Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279, Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin, ,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, 1675-02-1, EMU, ETs,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited